Current Firm
ARCH Venture Partners
Focus
Biotech, Digital Health
Mark McDonnell is a Managing Director at ARCH Venture Partners, a leading venture capital firm focused on early-stage scientific innovation. He invests across biotech, digital health, artificial intelligence, and deeptech sectors, identifying transformative technologies poised to create significant impact. At ARCH, McDonnell leverages deep expertise in emerging scientific domains to support founding teams in translating cutting-edge research into scalable businesses. His investment thesis centers on companies addressing fundamental challenges in healthcare and technology through novel scientific approaches. McDonnell is actively involved in sourcing, diligencing, and supporting portfolio companies through their critical early stages. His focus on converging scientific disciplines—from biotechnology to AI—reflects ARCH's commitment to backing the most ambitious technical founders and breakthrough technologies that define the next generation of innovation.
Mark McDonnell is a Managing Director, ARCH Venture Partners at ARCH Venture Partners, based in Chicago, IL.
Mark's investment focus spans Biotech, Digital Health, AI, Deeptech, primarily investing at the Seed, Series A stages. This specialization allows for deep domain knowledge and strong network effects that benefit portfolio companies.
Mark McDonnell is a Managing Director, ARCH Venture Partners at ARCH Venture Partners, based in Chicago, IL. Their investment focus includes Biotech, Digital Health, AI.
Mark McDonnell focuses on investments in Biotech, Digital Health, AI, Deeptech through ARCH Venture Partners. These focus areas reflect their domain expertise and the types of startups they actively seek to back.
Mark McDonnell is currently at ARCH Venture Partners, headquartered in Chicago, IL, serving as Managing Director, ARCH Venture Partners.